Literature DB >> 11687471

Enzyme-linked immunospot assays provide a sensitive tool for detection of cytokine secretion by monocytes.

M Kouwenhoven1, V Ozenci, N Teleshova, Y Hussein, Y M Huang, A Eusebio, H Link.   

Abstract

Blood monocytes as well as tissue-differentiated macrophages play a pivotal role in controlling immune reactions. Monocytes regulate the extent, nature, and duration of immune responses by secretion of cytokines. Interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-alpha), IL-10, and IL-12 are of particular interest, since IL-12 shifts the immune response towards a Th1 type, facilitating the production of, e.g., TNF-alpha and IL-6, while IL-10 counteracts Th1 responses and promotes the production of Th2-related cytokines such as IL-4. A tight regulation of these four cytokines keeps the balance and decides whether Th1 or Th2 will predominate in immune reactions. Enzyme-linked immunospot (ELISPOT) assays are among the most-sensitive and -specific methods available for cytokine research. They permit ex vivo identification of individual cells actively secreting cytokines. In the present study we prepared monocytes from healthy subjects' blood and adapted ELISPOT assays to define optimal conditions to detect and enumerate monocytes secreting IL-6, TNF-alpha, IL-10, and IL-12. The optimal time for monocyte incubation was 24 h, and optimal monocyte numbers (in cells per well) were 2,000 for IL-6, 1,000 for TNF-alpha, 50,000 for IL-10, and 100,000 for enumeration of IL-12 secreting monocytes. Among healthy subjects, 10% +/- 5% of the monocytes secreted IL-6, 12% +/- 12% secreted TNF-alpha, 0.1% +/- 0.1% secreted IL-10, and 0.2% +/- 0.3% secreted IL-12 (values are means +/- standard deviations). In conclusion, ELISPOT assays constitute a valuable tool to enumerate monocytes secreting IL-6, TNF-alpha, IL-10, and IL-12 and probably to enumerate monocytes secreting other cytokines and proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687471      PMCID: PMC96257          DOI: 10.1128/CDLI.8.6.1248-1257.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  IL-12 elispot assays to detect and enumerate IL-12 secreting cells.

Authors:  V Ozenci; M Kouwenhoven; R Press; H Link; Y M Huang
Journal:  Cytokine       Date:  2000-08       Impact factor: 3.861

2.  Measurement of serum cytokines.

Authors:  A Barnes
Journal:  Lancet       Date:  1998-07-25       Impact factor: 79.321

3.  Monocyte cytokine production in an elderly population: effect of age and inflammation.

Authors:  R Roubenoff; T B Harris; L W Abad; P W Wilson; G E Dallal; C A Dinarello
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1998-01       Impact factor: 6.053

Review 4.  The potential for monocyte-mediated immunotherapy during infection and malignancy. Part I: apoptosis induction and cytotoxic mechanisms.

Authors:  M A Williams; A C Newland; S M Kelsey
Journal:  Leuk Lymphoma       Date:  1999-06

5.  A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes.

Authors:  G M Graziani-Bowering; J M Graham; L G Filion
Journal:  J Immunol Methods       Date:  1997-09-24       Impact factor: 2.303

6.  Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis.

Authors:  A H van Boxel-Dezaire; S C Hoff; B W van Oosten; C L Verweij; A M Dräger; H J Adèr; J C van Houwelingen; F Barkhof; C H Polman; L Nagelkerken
Journal:  Ann Neurol       Date:  1999-06       Impact factor: 10.422

Review 7.  The potential for monocyte-mediated immunotherapy during infection and malignancy--Part II: in vivo activation by exogenous cytokines and clinical applications.

Authors:  M A Williams; C J Rhoades; A C Newland; S M Kelsey
Journal:  Leuk Lymphoma       Date:  1999-07

8.  Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.

Authors:  V Ozenci; M Kouwenhoven; Y M Huang; P Kivisäkk; H Link
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

9.  Interleukin-12 and perforin mRNA expression is augmented in blood mononuclear cells in multiple sclerosis.

Authors:  D Matusevicius; P Kivisäkk; V Navikas; M Söderström; S Fredrikson; H Link
Journal:  Scand J Immunol       Date:  1998-06       Impact factor: 3.487

10.  Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12.

Authors:  B Becher; M Blain; P S Giacomini; J P Antel
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

View more
  6 in total

1.  Reconfigurable microfluidic device with integrated antibody arrays for capture, multiplexed stimulation, and cytokine profiling of human monocytes.

Authors:  Tam Vu; Ali Rahimian; Gulnaz Stybayeva; Yandong Gao; Timothy Kwa; Judy Van de Water; Alexander Revzin
Journal:  Biomicrofluidics       Date:  2015-08-06       Impact factor: 2.800

Review 2.  Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction.

Authors:  Antonio Segovia-Zafra; Daniel E Di Zeo-Sánchez; Carlos López-Gómez; Zeus Pérez-Valdés; Eduardo García-Fuentes; Raúl J Andrade; M Isabel Lucena; Marina Villanueva-Paz
Journal:  Acta Pharm Sin B       Date:  2021-11-18       Impact factor: 11.413

3.  Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap.

Authors:  Yacine Bounab; Klaus Eyer; Sophie Dixneuf; Magda Rybczynska; Cécile Chauvel; Maxime Mistretta; Trang Tran; Nathan Aymerich; Guilhem Chenon; Jean-François Llitjos; Fabienne Venet; Guillaume Monneret; Iain A Gillespie; Pierre Cortez; Virginie Moucadel; Alexandre Pachot; Alain Troesch; Philippe Leissner; Julien Textoris; Jérôme Bibette; Cyril Guyard; Jean Baudry; Andrew D Griffiths; Christophe Védrine
Journal:  Nat Protoc       Date:  2020-08-12       Impact factor: 13.491

Review 4.  Measuring single-cell protein secretion in immunology: Technologies, advances, and applications.

Authors:  Olivia T M Bucheli; Ingibjörg Sigvaldadóttir; Klaus Eyer
Journal:  Eur J Immunol       Date:  2021-04-01       Impact factor: 5.532

5.  Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.

Authors:  Sachin M Apte; Saroj Vadhan-Raj; Lorenzo Cohen; Roland L Bassett; Ilyssa O Gordon; Charles F Levenback; Pedro T Ramirez; Stacie T Gallardo; Rebecca S Patenia; Michael E Garcia; Revathy B Iyer; Ralph S Freedman
Journal:  J Transl Med       Date:  2006-04-07       Impact factor: 5.531

6.  Potential applicability of cytokines as biomarkers of disease activity in rheumatoid arthritis: Enzyme-linked immunosorbent spot assay-based evaluation of TNF-α, IL-1β, IL-10 and IL-17A.

Authors:  Keerthie Dissanayake; Chandrika Jayasinghe; Priyani Wanigasekara; Ajith Sominanda
Journal:  PLoS One       Date:  2021-01-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.